ZEB1 and thyroid gland carcinoma: ZEB1/2 is targeted by miR-200a [osteosarcoma (104)], 200b [gastric cancer, oral squamous cell carcinoma, osteosarcoma (248, 257)], miR-200c [oral squamous cell carcinoma, prostate cancer (285, 329)], miR-141 [breast cancer (331)], and miR-429 [cervical cancer, osteosarcoma, thyroid cancer (103, 131, 302)].